Press Releases

OPIS and TrialHub Unite: Revolutionizing Clinical Trials with Patient-Centric Innovation

Arsenal March 24, 2024

SGD Pharma Expands Sterinity Line: New Vial Sizes Revolutionize Pharmaceutical Production

Arsenal March 24, 2024

Alimentiv and Satisfai Health Revolutionize IBD Trials with AI

Arsenal March 24, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Breaking Barriers: VelaVigo's Second US Partnership Signals Booming China-US Biotech Collaborations

Breaking Barriers: VelaVigo’s Second US Partnership Signals Booming China-US Biotech Collaborations

VelaVigo's Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

VelaVigo’s Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

Eli Lilly's Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Eli Lilly’s Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA